WHWK
NA
$2.32
-$0.18(-7.20%)
56
Overall
60
Value
66
Tech
44
Quality
Market Cap
$100.38M
Volume
136.50K
52W Range
$1.39 - $3.81
Target Price
$2.00
Company Overview
| Mkt Cap | $100.38M | Price | $2.32 |
| Volume | 136.50K | Change | -7.20% |
| P/E Ratio | -1.6 | Open | $2.47 |
| Revenue | $26.0M | Prev Close | $2.50 |
| Net Income | $-63.7M | 52W Range | $1.39 - $3.81 |
| Div Yield | N/A | Target | $2.00 |
| Overall | 56 | Value | 60 |
| Quality | 44 | Technical | 66 |
No chart data available
About NA
Whitehawk Therapeutics, Inc., an oncology therapeutics company that develops technologies to establish tumor biology for cancer treatments. It provides a three-asset antibody-drug conjugate (ADC) portfolio to treat cancer. The company was formerly known as Aadi Bioscience, Inc. and changed its name to Whitehawk Therapeutics, Inc. in March 2025. Whitehawk Therapeutics, Inc. was incorporated in 2007 and is headquartered in Morristown, New Jersey.
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | WHWK | $2.32 | -7.2% | 136.50K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |